Summary
Cancer cells do not share equal tumor-initiating potential. Only cancer stem cells (CSCs) can initiate cancer, which is important clinically because they should be eradicated to treat cancer patients. The purpose of experimental methods for identification of CSC is to isolate CSCs among various kinds of cancer cells in cancer masses. To identify CSCs, cancer masses derived from patients should be dissociated into single cells. Dissociated cells are classified into several groups according to expression status of one or several surface proteins using magnetic cell sorting (MACS) or fluorescence-activated cell sorting (FACS) methods. Sorted cells are cultured in a specialized culture medium for stem cells or inoculated into the primary cancer site of immunodeficient mice. In this chapter detailed experimental methods will be described and glioblastoma will be used as an example of solid cancers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., and Dirks, P. B. (2004) Identification of human brain tumour initiating cells. Nature. 432, 396–401.
Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., and Dirks, P. B. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821–5828.
Piccirillo, S. G., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., and Vescovi, A. L. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour initiating cells. Nature. 444, 761–765.
Stupp, R. and Hegi, M. E. (2007) Targeting brain-tumor stem cells. Nat. Biotechnol. 25, 193–194.
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., and Rich, J. N. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444, 756–760.
Dean, M., Fojo, T., and Bates, S. (2005) Tumour stem cells and drug resistance. Nat. Rev. Cancer. 5, 275–284.
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., Park, J. K., and Fine, H. A. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 9, 391–403.
Rietze, R. L., Valcanis, H., Brooker, G. F., Thomas, T., Voss, A. K., and Bartlett, P. F. (2001) Purification of a pluripotent neural stem cell from the adult mouse brain. Nature. 412, 736–739.
Nunes, M. C., Roy, N. S., Keyoung, H. M., Goodman, R. R., McKhann, G., 2nd, Jiang, L., Kang, J., Nedergaard, M., and Goldman, S. A. (2003) Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 9, 439–447.
Bonnet, D. and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730–737.
Matsui, W., Huff, C. A., Wang, Q., Malehorn, M. T., Barber, J., Tanhehco, Y., Smith, B. D., Civin, C. I., and Jones, R. J. (2004) Characterization of clonogenic multiple myeloma cells. Blood. 103, 2332–2336.
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 3983–3988.
O’Brien, C. A., Pollett, A., Gallinger, S., and Dick, J. E. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445, 106–110.
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., and De Maria, R. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature. 445, 111–115.
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., Fuhlbrigge, R. C., Kupper, T. S., Sayegh, M. H., and Frank, M. H. (2008) Identification of cells initiating human melanomas. Nature. 451, 345–349.
Vescovi, A. L., Galli, R., and Reynolds, B. A. (2006) Brain tumour stem cells. Nat. Rev. Cancer. 6, 425–436.
Sanai, N., Alvarez-Buylla, A., and Berger, M. S. (2005) Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811–822.
Zborowski, M. and Chalmers, J. J. (eds.) (2007) Magnetic Cell Separation. Elsevier, Amsterdam, The Netherlands.
Macey, M. G. (ed.) (2007) Flow Cytometry and Cell Sorting. Humana, Totowa, NJ.
Fidler, I. J. (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer. 3, 453–458.
Panchision, D. M., Chen, H. L., Pistollato, F., Papini, D., Ni, H. T., and Hawley, T. S. (2007) Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24. Stem Cells. 25, 1560–1570.
Schmid, I., Uittenbogaart, C. H., Krall, W. J., Braun, J., and Giorgi, J. V. (1992) Dead cell discrimination with 7-amio-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 13, 204–208.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Joo, K.M., Nam, DH. (2009). Prospective Identification of Cancer Stem Cells with the Surface Antigen CD133. In: Yu, J. (eds) Cancer Stem Cells. Methods in Molecular Biology, vol 568. Humana Press. https://doi.org/10.1007/978-1-59745-280-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-280-9_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-938-3
Online ISBN: 978-1-59745-280-9
eBook Packages: Springer Protocols